Literature DB >> 1413374

The Gordon Wilson Lecture. The ABC's of viral hepatitis.

S Krugman1.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1413374      PMCID： PMC2376677     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  9 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  JAMA       Date:  1967-05-01       Impact factor: 56.272

3.  The delta agent.

Authors:  M Rizzetto
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

4.  Parenterally transmitted non-A, non-B hepatitis: virus-specific antibody response patterns in hepatitis C virus-infected chimpanzees.

Authors:  D W Bradley; K Krawczynski; J W Ebert; K A McCaustland; Q L Choo; M A Houghton; G Kuo
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

5.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

6.  Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission.

Authors:  C E Stevens; P E Taylor; M J Tong; P T Toy; G N Vyas; P V Nair; J Y Weissman; S Krugman
Journal:  JAMA       Date:  1987-05-15       Impact factor: 56.272

7.  Molecular cloning and characterization of hepatitis A virus cDNA.

Authors:  J R Ticehurst; V R Racaniello; B M Baroudy; D Baltimore; R H Purcell; S M Feinstone
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

8.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

9.  Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type.

Authors:  M S Khuroo
Journal:  Am J Med       Date:  1980-06       Impact factor: 4.965
  9 in total
  4 in total

1.  Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations.

Authors:  Xinmei Wang; Bo Yu; Wei Ren; Xiaokui Mo; Chenguang Zhou; Hongyan He; Huliang Jia; Lu Wang; Samson T Jacob; Robert J Lee; Kalpana Ghoshal; L James Lee
Journal:  J Control Release       Date:  2013-10-08       Impact factor: 9.776

Review 2.  The evolution of infectious agents in relation to sex in animals and humans: brief discussions of some individual organisms.

Authors:  David L Reed; Russell W Currier; Shelley F Walton; Melissa Conrad; Steven A Sullivan; Jane M Carlton; Timothy D Read; Alberto Severini; Shaun Tyler; R Eberle; Welkin E Johnson; Guido Silvestri; Ian N Clarke; Teresa Lagergård; Sheila A Lukehart; Magnus Unemo; William M Shafer; R Palmer Beasley; Tomas Bergström; Peter Norberg; Andrew J Davison; Paul M Sharp; Beatrice H Hahn; Jonas Blomberg
Journal:  Ann N Y Acad Sci       Date:  2011-08       Impact factor: 5.691

3.  Hepatitis A: Epidemiology and prevention in developing countries.

Authors:  Elisabetta Franco; Cristina Meleleo; Laura Serino; Debora Sorbara; Laura Zaratti
Journal:  World J Hepatol       Date:  2012-03-27

Review 4.  A review of immunogenicity and tolerability of live attenuated Hepatitis A vaccine in children.

Authors:  Sameer Rao; J S Mao; Salman Motlekar; Zhuang Fangcheng; Ganesh Kadhe
Journal:  Hum Vaccin Immunother       Date:  2016-12       Impact factor: 3.452
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.